ASTX660

ASTX660 Suppliers list
Company Name: BeiJing Hwrk Chemicals Limted  
Tel: 0757-86329057 18934348241
Email: sales4.gd@hwrkchemical.com
Company Name: Nanjing Chemlin Chemical Co., Ltd  
Tel: 025-83697070 13770331960
Email: info@chemlin.com.cn
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Email: sales-cpd@caerulumpharma.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Company Name: ShangHai Angti Biotechnology Co., Ltd.  
Tel: 13764913901
Email: info@angtibio.com

ASTX660 manufacturers

  • ASTX660
  • ASTX660 pictures
  • $76.00
  • 2026-07-27
  • CAS:1799328-86-1
  • Purity: 99.85%
  • Supply Ability: 10g
  • ASTX660
  • ASTX660 pictures
  • 2025-03-16
  • CAS:1799328-86-1
  • Min. Order: 1MG
  • Purity: 98
  • Supply Ability: 100G
ASTX660 Basic information
Product Name:ASTX660
Synonyms:ASTX660 (ASTX 660;ASTX660;Ethanone, 1-[6-[(4-fluorophenyl)methyl]-2,3-dihydro-5-(hydroxymethyl)-3,3-dimethyl-1H-pyrrolo[3,2-b]pyridin-1-yl]-2-[(2R,5R)-5-methyl-2-[[(3R)-3-methyl-4-morpholinyl]methyl]-1-piperazinyl]-;ASTX660(Tolinapant);1-(6-(4-Fluorobenzyl)-5-(hydroxymethyl)-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-2-((2R,5R)-5-methyl-2-(((R)-3-methylmorpholino)methyl)piperazin-1-yl)ethanone;Inhibitor,inhibit,ASTX-660,ASTX660,IAP,ASTX 660;Tolinapant (ASTX660);ASTX660, 10 mM in DMSO
CAS:1799328-86-1
MF:C30H42FN5O3
MW:539.68
EINECS:
Product Categories:API
Mol File:1799328-86-1.mol
ASTX660 Structure
ASTX660 Chemical Properties
Boiling point 716.6±60.0 °C(Predicted)
density 1.169±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO:75.0(Max Conc. mg/mL);138.97(Max Conc. mM)
Ethanol:100.0(Max Conc. mg/mL);185.29(Max Conc. mM)
form A solid
pka13.30±0.10(Predicted)
color White to off-white
Safety Information
MSDS Information
ASTX660 Usage And Synthesis
UsesTolinapant (ASTX660) is an orally bioavailable dual antagonist of cellular inhibitor of apoptosis protein (cIAP) and X-linked inhibitor of apoptosis protein (XIAP).
in vivo

In HCC1806 xenografts in mice, Tolinapant (daily oral treatment) causes moderate tumor growth inhibition but not regression[1].

References[1] Tomoko Smyth, et al. Abstract 1287: The dual IAP antagonist, ASTX660, increases the anti-tumor activity of NSC 125973 in preclinical models of triple-negative breast cancer in vivo. Cancer Res 2016;76(14 Suppl).
ASTX660 Preparation Products And Raw materials
Tag:ASTX660(1799328-86-1) Related Product Information
AT-IAP ASTX660 PD 184161 Elesclomol Trimidox (hydrochloride) Exclusive JAK3 INHIBITOR I